DiaMedica Therapeutics Operating Cycle Over Time
| DMAC Stock | USD 7.90 0.50 5.95% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out DiaMedica Therapeutics Performance and DiaMedica Therapeutics Correlation. DiaMedica | Build AI portfolio with DiaMedica Stock |
Will Biotechnology sector continue expanding? Could DiaMedica diversify its offerings? Factors like these will boost the valuation of DiaMedica Therapeutics. Projected growth potential of DiaMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DiaMedica Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DiaMedica Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DiaMedica Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DiaMedica Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Cycle Analysis
Compare DiaMedica Therapeutics and related stocks such as Altimmune, Galectin Therapeutics, and enGene Holdings Common Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALT | 288 | 119 | 94.9196 | 73.899 | 14.6171 | 50.6076 | 69.7274 | 89.5 K | 158 | 104 | 552 | 483 | (13.6 K) | 4.2 K | 56.9 K | 51.2 K | 53.8 K |
| GALT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANNX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| DRTS | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (3.8 K) | (6.4572) | (6.4572) | (6.4572) | (5.81) | (6.1) |
| KRRO | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 10.1504 | 3.3555 | 3.7361 | 273 | 273 | 273 | 245 | 258 |
| DSGN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| DBVT | 196 | 196 | 6.4 K | 8.2 K | 10.6 K | 22.7 K | 307 | 307 | 155 | 306 | 75.216 | 563 | 597 | 324 | 914 | 1.1 K | 998 |
| GNLX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
DiaMedica Therapeutics and related stocks such as Altimmune, Galectin Therapeutics, and enGene Holdings Common Operating Cycle description
My Equities
My Current Equities and Potential Positions
| DiaMedica Therapeutics | DMAC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 301 Carlson Parkway, |
| Exchange | NASDAQ Exchange |
USD 7.9
Check out DiaMedica Therapeutics Performance and DiaMedica Therapeutics Correlation. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.